查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678546

避孕药具和设备市场规模、份额、趋势分析报告：产品、地区、细分市场预测，2025-2030 年

Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

预计 2024 年全球避孕药和避孕设备的市场规模将达到 311.8 亿美元，2025 年至 2030 年的复合年增长率为 6.0%。

有几个因素推动了避孕药市场的成长。主要驱动因素包括提高生殖健康意识和教育、对计划生育方法的需求不断增长、改善卫生基础设施和获取途径、以及改变消费者对更有效和更方便的避孕选择的偏好。这些因素导致全球对更广泛的避孕选择的需求，包括口服避孕药和长效可逆避孕药（LARC），如子宫内避孕器（IUD）和植入。

此外，对于青少年怀孕的健康问题、对现代避孕方法的认识不断提高以及对口服避孕药作为预防意外怀孕的主要手段的偏好日益增加，预计将在预测期内推动市场增长。此外，不断增加的产品创新、政府措施以及对妇女赋权和权利的关注也促进了该市场的成长。例如，2023年7月，纯孕激素口服避孕药Opil获得FDA核准用于非合併使用。

在预计预测期内，旨在减少意外怀孕和相关医疗费用的计划的实施以及用户意识的提高将推动该行业的发展。根据联合国人口基金会（UNFPA）的《2022年世界人口状况报告》，全球每年约有1.21亿人怀孕，其中近一半是意外怀孕。

此外，开发中国家的政府正在采取措施提高人们的避孕意识并增加人们获得避孕的机会。例如，2023年10月，印度卡纳塔克邦卫生署在国家计划生育计划下推出了两种新的女性避孕方法。政府营运的健康中心将提供皮下植入和注射剂，透过延长两次生育之间的时间来促进生殖健康和性健康。这些避孕方法可望推动新兴市场的避孕，并有助于市场发展。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 避孕药与避孕设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战
    • 市场机会分析
  • 避孕药具与避孕设备市场分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章 避孕药具和设备市场：按产品分類的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年产品市场占有率分析
  • 细分仪表板
  • 2018 年至 2030 年避孕药具及避孕设备市场（依产品划分）
    • 避孕药
    • 避孕装置

第 5 章 避孕药具和设备市场：按地区分類的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2024 年和 2030 年避孕药具和避孕设备各地区市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争格局

  • 主要市场参与企业的最新趋势/策略措施及影响分析
  • 公司分类
  • 企业市场分析
  • 战略地图
  • 公司简介
    • AbbVie Inc.
    • Afaxys, Inc.
    • Agile Therapeutics
    • Bayer AG
    • China Resources（Holdings）Co., Ltd.
    • Church & Dwight Co., Inc.
    • Cupid Limited
    • Helm AG
    • Johnson & Johnson Services, Inc.
    • Organon Group
    • Pfizer Inc.
    • Veru, Inc.
    • Viatris Inc.
Product Code: 978-1-68038-032-3

Market Size & Trends:

The global contraceptive drugs and devices market size was estimated at USD 31.18 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. Several factors are contributing to the growth of the contraceptive market. Increasing awareness and education about reproductive health, a rising demand for family planning methods, improved healthcare infrastructure and access, and a shift in consumer preferences toward more effective and convenient contraceptive options are all key drivers. These factors have led to a global demand for a wide range of contraceptive choices, including oral contraceptives and long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants.

Furthermore, health concerns related to teenage pregnancies, increased awareness of modern contraception methods, and a growing preference for oral contraceptives as the primary means of preventing unplanned pregnancies are anticipated to drive market growth during the forecast period. In addition, advancements in product innovation, government initiatives, and a focus on women's empowerment and rights have contributed to this market growth. For instance, in July 2023, Opill, a progestin-only oral contraceptive pill, got approval by the FDA for nonprescription use.

Implementing programs aimed at reducing unwanted pregnancies and related healthcare costs, along with increasing awareness among users, is expected to drive growth in the industry during the forecast period. According to the 2022 State of World Population Report by the United Nations Population Fund (UNFPA), approximately 121 million pregnancies occur worldwide each year, with nearly half of them being unintended.

Moreover, governments in developing countries are undertaking steps to increase awareness and access to contraceptives. For instance, in October 2023, the Karnataka Health Department in India launched two new contraceptive methods for women under the National Family Planning Programme. The sub-dermal implant and subcutaneous injection were made available at government-run health centers to promote reproductive and sexual health by extending the interval between two births. Such methods are expected to promote the use of contraception in developing countries and contribute to the market's growth.

Global Contraceptive Drugs And Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product, and region.

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectable
  • Contraceptive Devices
    • Condoms
    • Male Condoms
    • Female Condoms
    • Subdermal Implants
    • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
    • Vaginal Ring
    • Diaphragm
  • Regional Outlook (Revenue, USD Billion, 2018-2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Secondary Sources
    • 1.4.2. List of Primary Sources
    • 1.4.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamic
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing awareness and education on reproductive health
      • 3.2.1.2. Rising demand for family planning methods
      • 3.2.1.3. Growing healthcare infrastructure and access
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects and health concerns
    • 3.2.3. Industry Challenges
    • 3.2.4. Market Opportunity Analysis
  • 3.3. Contraceptive Drugs and Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Contraceptive Drugs and Devices Market: By Product, 2018 to 2030
    • 4.4.1. Contraceptive Drugs
      • 4.4.1.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.2. Contraceptive Pills
        • 4.4.1.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.3. Patch
        • 4.4.1.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.4. Injectable
        • 4.4.1.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Contraceptive Devices
      • 4.4.2.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.2. Condoms
        • 4.4.2.2.1. Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.2.2. Male Condoms
          • 4.4.2.2.2.1. Male Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.2.3. Female Condoms
          • 4.4.2.2.3.1. Female Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.3. Subdermal Implants
        • 4.4.2.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.4. Intrauterine Devices (IUDs)
        • 4.4.2.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.4.2. Copper IUDs
          • 4.4.2.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.4.3. Hormonal IUDs
          • 4.4.2.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.5. Vaginal Ring
        • 4.4.2.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.6. Diaphragm
        • 4.4.2.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis by Region, Product

  • 5.1. Definition and Scope
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Regional Market Dashboard
  • 5.4. Contraceptive Drugs and Devices Market Share, By Region, 2024 & 2030, (USD Billion)
  • 5.5. North America
    • 5.5.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.2. U.S.
      • 5.5.2.1. U.S. Key Country Dynamics
      • 5.5.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Canada
      • 5.5.3.1. Canada Key Country Dynamics
      • 5.5.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. Mexico
      • 5.5.4.1. Mexico Key Country Dynamics
      • 5.5.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Europe
    • 5.6.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. UK
      • 5.6.2.1. UK Key Country Dynamics
      • 5.6.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. U.K. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. Germany
      • 5.6.3.1. Germany Key Country Dynamics
      • 5.6.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. France
      • 5.6.4.1. France Key Country Dynamics
      • 5.6.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. Italy
      • 5.6.5.1. Italy Key Country Dynamics
      • 5.6.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. Spain
      • 5.6.6.1. Spain Key Country Dynamics
      • 5.6.6.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Denmark
      • 5.6.7.1. Denmark Spain Key Country Dynamics
      • 5.6.7.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.8. Sweden
      • 5.6.8.1. Sweden Key Country Dynamics
      • 5.6.8.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.8.3. Competitive Insights
      • 5.6.8.4. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.9. Norway
      • 5.6.9.1. Norway Key Country Dynamics
      • 5.6.9.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.9.3. Competitive Insights
      • 5.6.9.4. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.2. China
      • 5.7.2.1. China Key Country Dynamics
      • 5.7.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.3. Japan
      • 5.7.3.1. Japan Key Country Dynamics
      • 5.7.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.4. India
      • 5.7.4.1. India Key Country Dynamics
      • 5.7.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.4.3. Competitive Insights
      • 5.7.4.4. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.5. South Korea
      • 5.7.5.1. South Korea Key Country Dynamics
      • 5.7.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.5.3. Competitive Insights
      • 5.7.5.4. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.6. Australia
      • 5.7.6.1. Australia Key Country Dynamics
      • 5.7.6.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.6.3. Competitive Insights
      • 5.7.6.4. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.7. Thailand
      • 5.7.7.1. Thailand Key Country Dynamics
      • 5.7.7.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.7.3. Competitive Insights
      • 5.7.7.4. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Latin America
    • 5.8.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.2. Brazil
      • 5.8.2.1. Brazil Key Country Dynamics
      • 5.8.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.3. Argentina
      • 5.8.3.1. Argentina Key Country Dynamics
      • 5.8.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Middle East and Africa (MEA)
    • 5.9.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.2. South Africa
      • 5.9.2.1. South Africa Key Country Dynamics
      • 5.9.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.2.3. Competitive Insights
      • 5.9.2.4. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Saudi Arabia Key Country Dynamics
      • 5.9.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.3.3. Competitive Insights
      • 5.9.3.4. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.4. UAE
      • 5.9.4.1. UAE Key Country Dynamics
      • 5.9.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.4.3. Competitive Insights
      • 5.9.4.4. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.5. Kuwait
      • 5.9.5.1. Kuwait Key Country Dynamics
      • 5.9.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.5.3. Competitive Insights
      • 5.9.5.4. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments/ Strategic Initiatives & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Position Analysis
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles
    • 6.5.1. AbbVie Inc.
      • 6.5.1.1. Participant's Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Recent Developments/ Strategic Initiatives
    • 6.5.2. Afaxys, Inc.
      • 6.5.2.1. Participant's Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Recent Developments/ Strategic Initiatives
    • 6.5.3. Agile Therapeutics
      • 6.5.3.1. Participant's Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Recent Developments/ Strategic Initiatives
    • 6.5.4. Bayer AG
      • 6.5.4.1. Participant's Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Recent Developments/ Strategic Initiatives
    • 6.5.5. China Resources (Holdings) Co., Ltd.
      • 6.5.5.1. Participant's Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Recent Developments/ Strategic Initiatives
    • 6.5.6. Church & Dwight Co., Inc.
      • 6.5.6.1. Participant's Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Recent Developments/ Strategic Initiatives
    • 6.5.7. Cupid Limited
      • 6.5.7.1. Participant's Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Recent Developments/ Strategic Initiatives
    • 6.5.8. Helm AG
      • 6.5.8.1. Participant's Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Recent Developments/ Strategic Initiatives
    • 6.5.9. Johnson & Johnson Services, Inc.
      • 6.5.9.1. Participant's Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Recent Developments/ Strategic Initiatives
    • 6.5.10. Organon Group
      • 6.5.10.1. Participant's Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Recent Developments/ Strategic Initiatives
    • 6.5.11. Pfizer Inc.
      • 6.5.11.1. Participant's Overview
      • 6.5.11.2. Financial Performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Recent Developments/ Strategic Initiatives
    • 6.5.12. Veru, Inc.
      • 6.5.12.1. Participant's Overview
      • 6.5.12.2. Financial Performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Recent Developments/ Strategic Initiatives
    • 6.5.13. Viatris Inc.
      • 6.5.13.1. Participant's Overview
      • 6.5.13.2. Financial Performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 4 U.S. contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 5 Canada contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 6 Mexico contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 7 Europe contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 8 UK contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 9 Germany contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 10 France contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 11 Italy contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 12 Spain contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 13 Denmark contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 14 Sweden contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 15 Norway contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 17 Japan contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 18 China contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 19 India contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 20 Australia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 21 South Korea contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 22 Thailand contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 23 Latin America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 24 Brazil contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 25 Argentina contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 26 MEA contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 27 South Africa contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 28 Saudi Arabia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 29 UAE contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 30 Kuwait contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Contraceptive Drugs and Devices Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 Contraceptive Drugs and Devices- Market Size and Growth Prospects (USD Billion)
  • Fig. 11 Contraceptive Drugs and Devices Market: Market Dynamics
  • Fig. 12 Contraceptive Drugs and Devices Market: PORTER's Analysis
  • Fig. 13 Contraceptive Drugs and Devices Market: PESTEL Analysis
  • Fig. 14 Contraceptive Drugs and Devices Market Share by Product 2024 & 2030 (USD Billion)
  • Fig. 15 Contraceptive Drugs and Devices Market, by Product: Key Takeaways
  • Fig. 16 Contraceptive Drugs and Devices Market, by Product: Market Share, 2024 & 2030
  • Fig. 17 Contraceptive Drugs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 18 Contraceptive Pills Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 19 Patch Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 20 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 21 Contraceptive Devices Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 22 Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 23 Male Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 24 Female Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 25 Subdermal Implants Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 26 Intrauterine Devices (IUDs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 27 Copper IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 28 Hormonal IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 29 Vaginal Ring Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 30 Diaphragm Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 31 Contraceptive Drugs and Devices Market Revenue, by Region, 2024 & 2030 (USD Billion)
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030) (USD Billion)
  • Fig. 40 Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 MEA Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Key Company Categorization
  • Fig. 63 Company Market Positioning
  • Fig. 64 Key Company Market Share Analysis, 2024
  • Fig. 65 Strategic Framework